Literature DB >> 12479252

Assessment for addiction in pain-treatment settings.

Seddon R Savage1.   

Abstract

The identification of the disease of addiction is important to safe and effective clinical management of pain in persons with addictive disorders. The disease of addiction affects approximately 10% of the general population, and its prevalence may be higher in subpopulations of patients with pain. The presence of active addiction may facilitate the experience of pain. Both active and recovering addiction may complicate the use of medications, such as opioids, important to the management of pain. There is, further, persistent misunderstanding among health care providers, regulators, and the general population regarding the nature and manifestations of addiction that may result in undertreatment of pain and stigmatization of patients using opioids for pain control. The author seeks to clarify understanding of addiction, to underscore the importance of identifying addiction in the context of pain treatment, and to provide a rational approach to assessment for addiction in patients with pain. Current scientific understanding of addiction as a chronic illness is briefly reviewed. Recent definitions related to addiction are presented. The impact of addictive disorders on pain and pain treatment are explored. The roles of medical interview, physical examination, laboratory studies, and standard addiction screening tools in assessing for addiction are outlined. Differential considerations in distinguishing therapeutic use of opioids for analgesia from addictive or other nontherapeutic use of opioids are discussed. In summary, the article provides salient background and a detailed approach to assessment for addictive disorders in the context of pain treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12479252     DOI: 10.1097/00002508-200207001-00004

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  34 in total

1.  Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.

Authors:  David I Buckley; James F Calvert; Jodi A Lapidus; Cynthia D Morris
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

2.  Screening for addictive disorders within a workers' compensation clinic: an exploratory study.

Authors:  Iman Parhami; Mark Hyman; Aaron Siani; Stephanie Lin; Michael Collard; Johnny Garcia; Laurie Casaus; John Tsuang; Timothy W Fong
Journal:  Subst Use Misuse       Date:  2011-11-08       Impact factor: 2.164

3.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

Review 4.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 5.  Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem.

Authors:  Kirsten Auret; Stephan A Schug
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Use of opioids for treatment of osteoporotic pain.

Authors:  Renato Vellucci; Rocco Domenico Mediati; Giovanna Ballerini
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

7.  Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

Authors:  Stephen F Butler; Kathrine Fernandez; Christine Benoit; Simon H Budman; Robert N Jamison
Journal:  J Pain       Date:  2008-01-22       Impact factor: 5.820

8.  Validation of a brief Opioid Compliance Checklist for patients with chronic pain.

Authors:  Robert N Jamison; Marc O Martel; Robert R Edwards; Jing Qian; Kerry Anne Sheehan; Edgar L Ross
Journal:  J Pain       Date:  2014-08-01       Impact factor: 5.820

9.  A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework.

Authors:  Lynn L Debar; Lindsay Kindler; Francis J Keefe; Carla A Green; David H Smith; Richard A Deyo; Katharine Ames; Adrianne Feldstein
Journal:  Transl Behav Med       Date:  2012-08-30       Impact factor: 3.046

10.  Gender differences in risk factors for aberrant prescription opioid use.

Authors:  Robert N Jamison; Stephen F Butler; Simon H Budman; Robert R Edwards; Ajay D Wasan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.